spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 1


Fig. 1. TtT/GF cell apoptosis following long-term treatment with TNF{alpha}. TtT/GF cells were incubated with culture medium alone (control) or with medium containing 20 ng/ml TNF{alpha} (TNF{alpha}) for increasing periods of time. (A) The phase-contrast micrographs show control TtT/GF cells with a typical morphology of spreading cells with abundant filopodia and lamellipodia. After 48-96 hours in culture, the cells became elongated and lamellipodia became less abundant. Following TNF{alpha} treatment, the cells progressively lost the membrane extensions, they shrunk and detached. Scale bar: 250 µm. Inset: Differential interference contrast microscopy shows membrane blebbings of detached cells that had been treated with TNF{alpha} for 96 hours. Scale bar: 25 µm. (B) Representative western blots demonstrating the absence and the presence of active caspase 8 in total-cell lysates from control and TNF{alpha}-treated cells, respectively. (C) Following treatments, total-cell lysates were obtained and subjected to electrophoresis and western blotting with an antibody that exclusively recognises the active caspase 3 fragment and with anti-actin (loading control). The representative western blots show a 17 kDa band corresponding to the active caspase 3 in cells that had been treated with TNF{alpha} for 72 hours and 96 hours, but not in control TtT/GF cells. (D) TtT/GF cells were incubated with either control culture medium or culture medium containing TNF{alpha} (20 ng/ml final concentration) both in the absence or in the presence of the caspase inhibitor Z-VADfmk (5 µM, final concentration) for 96 hours. Following treatments, total cell lysates (T), non-cytoskeleton (N) and cytoskeleton (C) fractions were obtained and subjected to electrophoresis and western blotting with an anti-active caspase 3. Cleaved caspase 3 was recovered in the cytoskeleton fraction and the cleavage was blocked by Z-VAD-fmk. (E) Time-course studies showing the increased chromatin condensation ({dagger}P<0.001, 72 hours vs 48 hours), nucleosome release (*P<0.0001, 48 hours vs 24 hours) and cell detachment (**P<0.0002, 48 hours vs 24 hours) in TNF{alpha}-treated TtT/GF cells. Chromatin condensation in apoptotic cells was evaluated by labelling the cells with Hoechst 33342 and propidium iodide. Nucleosome release was measured by quantifying cytoplasmic histone-associated-DNA fragments (mono and oligonucleosomes). Cell detachment was quantified by counting detached cells with a hemocytometer. Data from three independent experiments are expressed as the ratio of treated to control cells ± s.e.m. (F) TNF{alpha}-induced cell shrinkage and detachment were blocked by caspase inhibition (scale bar: 50 µm). (G) TNF{alpha}-induced nucleosome release was blocked by the caspase inhibitor Z-VAD-fmk. (H) After incubation with medium alone (control) or containing TNF{alpha} for increasing periods of time, total cell lysates were subjected to electrophoresis and western blotting with {alpha}-actinin and spectrin antibodies. The representative western blot shows {alpha}-actinin downregulation and spectrin cleavage into two fragments of 120 kDa and 150 kDa of molecular mass, respectively (arrows) in TNF{alpha}-treated cells.





Right arrow Return to article